Sunday 19 February 2017

PRO> Influenza (05): seasonal vaccine studies

Influenza -- Worldwide/Unknown
Summary Abstract:
We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1 percent, 46.9 percent and 23.4 percent among 0-14, 15-64 and 65 year-olds, and 25.7 percent in the influenza vaccination target group. At hospital level, IVE was 2.5 percent, 7.9 percent, and 2.4 percent among 65, 65-79, and 80 year-olds. As in previous

Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2kMSGq3

No comments:

Post a Comment